Recommendations: Include vaccination against COVID-19 with bivalent vaccine in the pediatric population (from 6 months of age); Reaffirmation of the NITAG recommendation of January 2023, based on the current availability of bivalent vaccine the NITAG considers it important to prioritize it in the

The use of bivalent vaccines against COVID-19: Based on the safety data on the use of
bivalent vaccines (BA.4/BA.5)8,9 CONAPI states that the Moderna and/or Pfizer bivalent vaccines

El NITAG recomienda la inclusión en el Calendario Nacional de Vacunación de la vacuna Polio IPV de 5 dosis a partir de 2024. A partir de septiembre de 2023, el calendario nacional cambiará de dos dosis a una dosis única para todas las niñas e incluirá a los niños de 9 años.